Generalized cytochrome P450-mediated oxidation and oxygenation reactions in aromatic substrates with activated N-H, O-H, C-H, or S-H substituents

References

• Åström A., De Pierre J. W. Metabolism of 2-acetylaminofluorine by eight different forms of cytochrome P-450 isolated from rat liver. Carcinogenesis 1985; 6: 113–120
   PubMed Web of Science ®Google Scholar
• Augusto O., Beilan H. S., Oritz De Montellano P. R. The catalytic mechanism of cytochrome P-450. Spin-trapping evidence for one-electron substrate oxidation. Journal of Biological Chemistry 1982; 257: 11288–11295
   PubMed Web of Science ®Google Scholar
• Cavalieri E. L., Rogan E. G. Radical cations in aromatic hydrogen carcinogenesis. Free Radical Research Communication 1990; 11: 77–87
   PubMed Web of Science ®Google Scholar
• Gillette J. R., Nelson S. D., Mulder G. J., Jollow D. J., Mitchell J. R., Pohl L. R., Hinson J. A. Formation of chemically reactive metabolites of phenacetine and acetaminophen. Biological Reactive Intermediates-II: Chemical Mechanisms and Biological Effects, R. Snyder, D. V. Parke, J. J. Korsis, D. J. Jollow, G. G. Gibson, C. M. Witmer. Plenum, New York 1982; 931–950
   Google Scholar
• Goldstein J. A., Weaver R., Sundheimer D. W. Metabolism of 2-acetylaminofluorene by two 3-methylcholantrene-inducible forms of rat liver cytochromes P-450. Cancer Research 1984; 44: 3768–3775
   PubMed Web of Science ®Google Scholar
• Gonzales F. J. The molecular biology of cytochrome P450s. Pharmacological Reviews 1989; 40: 243–288
   Web of Science ®Google Scholar
• Groves J. T., McClusky G. A. Aliphatic hydroxylation by highly purified liver microsomal cytochrome P-450. Evidence for a carbon radical intermediate. Biochemical and Biophysical Research Communications 1978; 81: 154–160
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Macdonald T. L. Mechanisms of cytochrome P-450 catalysis. FASEB Journal 1990; 4: 2453–2459
   PubMed Web of Science ®Google Scholar
• Hammons G. J., Guengerich F. P., Weis C. C., Beland F. A., Kadlubar F. F. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases. Cancer Research 1985; 45: 3578–3585
   PubMed Web of Science ®Google Scholar
• Hanzlik R. P., Hogberg K., Judson C. M. Microsomal hydroxylation of specifically deuterated monosubstituted benzenes. Evidence for direct aromatic hydroxylation. Biochemistry 1984; 23: 3048–3055
   PubMed Web of Science ®Google Scholar
• Hanzlik Schaefer R. P. A. R., Moon J. B., Judson C. M. Primary and secondary kinetic deuterium isotope effects and transition-state structures foe benzylic chlorination and bromination of toluene. Journal of the American Chemical Society 1987; 109: 4926–4930
   Web of Science ®Google Scholar
• Harvison P. J., Forte A. J., Nelson S. D. Comparative toxicities and analgesic activities of three mono-methylated analogues of acetaminophen. Journal of Medicinal Chemistry 1986; 29: 1737–1743
   PubMed Web of Science ®Google Scholar
• Hinson J. A. Reactive metabolites of phenacetin and acetaminophen: a review. Environmental Health Perspectives 1983; 49: 71–79
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Mitchell J. R., Jollow D. J. MicrosomalN-hydroxylation ofp-chloro-acetanilide. Molecular Pharmacology 1975; 11: 462–469
   Web of Science ®Google Scholar
• Hinson J. A., Nelson S. D., Gillette J. R. Metabolism of [p-18O]-phenacetin: the mechanism of activation of phenacetin to reactive metabolites in hamsters. Molecular Pharmacology 1979; 15: 419–427
   PubMed Web of Science ®Google Scholar
• Hinson J., Nelson S. D., Mitchel J. R. Studies on the microsomal formation of arylating metabolites of acetaminophen and phenacetin. Molecular Pharmacology 1977; 13: 625–633
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Pohl L. R., Monks T. J., Gillette J. R., Guengerich F. P. 3-Hydroxyacetaminophen: a microsomal metabolite of acetaminophen. Evidence against an epoxide as the reactive metabolite of acetaminophen. Drug Metabolism and Disposition 1980; 8: 289–294
   PubMed Web of Science ®Google Scholar
• Hoffmann K.-J., Axworthy D. B., Baillie T. A. Mechanistic studies on the metabolic activation of acetaminophen, in vivo. Chemical Research in Toxicology 1990; 3: 204–211
   PubMed Web of Science ®Google Scholar
• Hongslo J. K., BjØRnstad C., Schwarze P. E., Holme J. A. Inhibition of replicative DNA-synthesis by paracetamol in V79 Chinese hamster cells. Toxicology in Vitro 1989; 3: 13–20
   PubMed Web of Science ®Google Scholar
• Hyslop R. M., Jardine I. Metabolism of 6-thiopurines. 1. Irreversible binding of a metabolite of 6-thiopurine to mammalian hepatic protein. in vitro. Journal of Pharmacology and Experimental Therapeutics 1981; 218: 621–628
   PubMed Web of Science ®Google Scholar
• Kao J., Faulkner J., Bridges J. W. Metabolism of aniline in rats, pigs and sheep. Drug Metabolism and Disposition 1978; 6: 549–555
   PubMed Web of Science ®Google Scholar
• Korzekwa K. R., Jones J. P., Gillette J. R. Theoretical studies on cytochrome P450-mediated hydroxylation: a predictive model for hydrogen atom abstractions. Journal of the American Chemical Society 1990; 112: 7042–7046
   Web of Science ®Google Scholar
• Koymans L., Van Lenthe J. H., DonnÉ-Op Den Kelder G. M., Vermeulen N. P. E. Mechanisms of activation of phenacetin to reactive metabolites by cytochrome P450: a theoretical study involving radical intermediates. Molecular Pharmacology 1990; 37: 452–460
   PubMed Web of Science ®Google Scholar
• Koymans L., Van Lenthe J. H., Van De Straat R., DonnÉ-Op Den Kelder G. M., Vermeulen N. P. E. A theoretical study on the metabolic activation of paracetamol by cytochrome P-450: indications for a uniform oxidation mechanism. Chemical Research in Toxicology 1989; 2: 60–66
   PubMed Web of Science ®Google Scholar
• Koymans L., Menge W. M. P. B., Van Lenthe J. H., DonnÉ-Op Den Kelder G. M., Koppele Te J. M., Vermeulen N. P. E. A theoretical study on the oxidative metabolism of 4-chloro-acetanilide by cytochrome P450: alternative mechanisms for migration of 4-substituents during enzymatic oxidation. Recueil des Travaux Chimiques des Pays-Bas 1993; 112: 186–190
   Google Scholar
• Lee J. S., Jacobsen N. E., Ortiz De Montallano P. R. 4-Alkyl radical extrusion in the cytochrome P-450 catalyzed oxidation of 4-alkyl-1,4-dihydropyridines. Biochemistry 1988; 27: 7703–7710
   PubMed Web of Science ®Google Scholar
• Letteron P., Fouin-Fortunet H., Tinel M., Danan G., Belghiti J., Pessayre D. Mechanism for isaxonine hepatitis. 1. Metabolic activation by mouse and human cytochrome P450. Journal of Pharmacology and Experimental Therapeutics 1984; 229: 845–850
   PubMed Web of Science ®Google Scholar
• Ling K.-H. J., Hanzlik R. P. Deuterium isotope effects on toluene metabolism. Product release as rate limiting step in cytochrome P450-catalysis. Biochemical and Biophysical Research Communications 1989; 160: 844–849
   PubMed Web of Science ®Google Scholar
• Malkinson A. M. Prevention of butylated hydroxytoluene-induced lung damage in mice by cedar terpene administration. Toxicology and Applied Pharmacology 1979; 49: 551–560
   PubMed Web of Science ®Google Scholar
• McMahon R. E., Turner J. C., Whitaker G. W. TheN-hydroxylation and ring-hydroxylation of 4-aminobiphenylin vitro by hepatic monooxygenases from rat, mouse, hamster, rabbit and guinea pig. Xenobiotica 1980; 10: 469–481
   PubMed Web of Science ®Google Scholar
• Moore M., Thor H., Moore Nelson G. S., MoldÉUs P., Orrenius S. The toxicity of acetaminophen andN-acetylp-benzoquinone imine in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+. Journal of Biological Chemistry 1985; 260: 13035–13040
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Nelson D. R., Adesnik M., Coon M., Estabrook R. W., Gonzales F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Kemper B., Levin W., Phillips I. R., Sato R., Waterman M. R. P450-superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. DNA 1989; 8: 1–13
   PubMedGoogle Scholar
• Nebert D. W., Nelson D. R., Coon M. J., Estabrook R., Feyereisen R., Fujii-Kuriyama Y., Gonzales F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Loper J. C., Sato R., Waterman M. R., Waxman D. J. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA and Cell Biology 1991a; 10: 1–14
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Nelson D. R., Coon M. J., Estabrook R. W., Feyerisen R., Fujii-Kuriuama Y., Gonzales F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Loper J. C., Sato R., Waterman M. R., Waxman D. J. Corrigendum. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA and Cell Biology 1991b; 10: 397–398
   Web of Science ®Google Scholar
• Nelson S. D., Forte A. J., McMurtry R. J. Decreased toxicity of theN-methyl analogue of acetaminophen and phenacetine. Research Communications in Chemical Pathology and Pharmacology 1978; 22: 61–71
   PubMedGoogle Scholar
• Nelson S. D., Forte A. J., Vaishnav Y., Mitchell J. R., Gillette J. R., Hinson J. A. The formation of arylating and alkylating metabolites of phenacetin in hamsters and hamster microsomes. Molecular Pharmacology 1981; 19: 140–145
   PubMed Web of Science ®Google Scholar
• Nelson S. D., Harvison P. J. Roles of cytochromes P-450 in chemically induced cytotoxicity. Mammalian Cytochromes P-450, F. P. Guengerich. CRC Press, Boca Raton, FL 1987; Vol. II: 19–79
   Google Scholar
• Nelson D. R., Strobel H. W. Evolution of cytochrome P-450 proteins. Molecular Biology and Evolution 1987; 4: 572–593
   PubMed Web of Science ®Google Scholar
• Ortiz De Montellano P. R. Cytochrome P450 catalysis: radical intermediates and dehydrogenation reactions. Trends in Pharmacological Sciences 1989; 10: 354–359
   PubMed Web of Science ®Google Scholar
• Persson J. O., Terelius Y., Ingelman-Sundberg M. Cytochrome P450-dependent formation of reactive oxygen radicals; isoenzyme-specific inhibition of P450-mediated reduction of oxygen radicals; isoenzyme-specific inhibition of P450-mediated reduction of oxygen and carbon tetrachloride. Xenobiotica 1990; 20: 887–901
   PubMed Web of Science ®Google Scholar
• Rashed M. S., Nelson S. D. Characterization of glutathione conjugates of reactive metabolites of 3′-hydroxyacetanilide, a non-hepatotoxic positional isomer of acetaminophen. Chemical Research in Toxicology 1989; 2: 41–45
   PubMed Web of Science ®Google Scholar
• Rietjens I. M. C. M., Tyrakowska B., Veeger C., Vervoort J. Reaction pathways for biodehalogenation of fluorinated anilines. European Journal of Biochemistry 1990; 194: 945–954
   PubMedGoogle Scholar
• Sahawata T., Neal R. A. Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes. Molecular Pharmacology 1983; 23: 453–460
   PubMed Web of Science ®Google Scholar
• Shoemaker D. D., Cysyk R. L., Gormely P. E., De Souza J. J. V., Malspeis L. Metabolism of 4′-(9-acridinylamino)methanesulfon-m-aniside by rat liver microsomes. Cancer Research 1984; 44: 1939–1945
   PubMed Web of Science ®Google Scholar
• Smith B. R., Plummer J. L., Wolf C. R., Philpot R. M., Bend J. R. p-Xylene metabolism by rabbit lung and liver and its relationship to the selective destruction of pulmonary cytochrome P-450. Journal of Pharmacology and Experimental Therepaeutics 1982; 223: 736–743
   PubMed Web of Science ®Google Scholar
• Streeter Bjorge A. J. S. M., Axworthy D. B., Nelson S. D., Baillie T. A. The microsomal metabolism and site of covalent binding to protein of 3′-hydroxyacetanilide, a non-hepatotoxic positional isomer of acetaminophen. Drug Metabolism and Disposition 1984; 12: 565–576
   PubMed Web of Science ®Google Scholar
• Thompson J. A., Malkinson A. M., Wand M. D., Mastovich S. L., Mead E. W., Schullek K. M., Laudenschlager W. G. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice. Drug Metabolism and Disposition 1987; 5: 833–840
   Google Scholar
• Uetrecht J. P., Sweetman B. J., Woosley R. L., Oates J. A. Metabolism of procainamide to a hydroxylamine by rat and human hepatic microsomes. Drug Metabolism and Disposition 1984; 12: 77–81
   PubMed Web of Science ®Google Scholar
• Uetrecht J. P., Woosley R. L., Freeman R. W., Sweetman B. J., Oates J. A. Metabolism of procainamide in the perfused rat liver. Drug Metabolism and Disposition 1981; 9: 183–187
   PubMed Web of Science ®Google Scholar
• Ullrich V., Wolf J., Amadori E., Standinger H. Mixed-function oxygenation of 4-halogeno-acetanilides in rat liver microsomes and model systems. Hoppe Seyler's Zeitschrift für physiologischen Chemie 1968; 349: 85–94
   PubMedGoogle Scholar
• Van De Straat R., De Vries J., Groot E. J., Zijl R., Vermeulen N. P. E. Paracetamol, 3-monoalkyl- and 3,5-dialkyl derivatives: comparison of theirin vivo hepatotoxicity in mice. Toxicology and Applied Pharmacology 1987; 89: 183–189
   PubMed Web of Science ®Google Scholar
• Van Ommen B., Adang A., Müller F., Van Bladeren P. J. The microsomal metabolism of pentachlorophenol and its covalent binding to protein and DNA. Chemico-Biological Interactions 1986; 60: 1–11
   PubMed Web of Science ®Google Scholar
• White R. E. The involvement of free radicals in the mechanisms of monooxygenases. Pharmacology and Therapeutics 1991; 49: 21–42
   PubMed Web of Science ®Google Scholar
• White R. E., Miller J. P., Favreau L. V., Bhattacharyya A. Stereochemical dynamics of aliphatic hydroxylation by cytochrome P-450. Journal of the American Chemical Society 1986; 108: 6024–6031
   PubMed Web of Science ®Google Scholar